Paper40385486
Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease.
AlRasheed HA and 17 others. Front Pharmacol, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease. Papers, record 40385486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40385486
- Disease
- Parkinson disease333 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05781711 | Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease | Derived from the trial | Yes |
Source ClinicalTrials.gov
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34396446 | Metformin inhibits cholesterol‑induced adhesion molecule expression via activating the AMPK signaling pathway in vascular smooth muscle cells. | Mol Med Rep | 2021 | https://conductscience.org/library/papers/34396446 | PubMed |
| 2 | 39225830 | Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39225830 | PubMed |
| 3 | 35982135 | Tanshinone IIA reduces AQP4 expression and astrocyte swelling after OGD/R by inhibiting the HMGB1/RAGE/NF-κB/IL-6 pro-inflammatory axis. | Sci Rep | 2022 | https://conductscience.org/library/papers/35982135 | PubMed |
| 4 | 36757031 | Homocysteine, Vitamin B12 and Folate Level: Possible Risk Factors in the Progression of Chronic Heart and Kidney Disorders. | Curr Cardiol Rev | 2023 | https://conductscience.org/library/papers/36757031 | PubMed |
| 5 | 30310233 | Drug repurposing: progress, challenges and recommendations. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30310233 | PubMed |
| 6 | 28283884 | Resveratrol and Brain Mitochondria: a Review. | Mol Neurobiol | 2018 | https://conductscience.org/library/papers/28283884 | PubMed |
| 7 | 29288112 | The genetics of Parkinson disease. | Ageing Res Rev | 2018 | https://conductscience.org/library/papers/29288112 | PubMed |
| 8 | 39177895 | Blunted Melatonin Circadian Rhythm in Parkinson's Disease: Express Bewilderment. | Neurotox Res | 2024 | https://conductscience.org/library/papers/39177895 | PubMed |
| 9 | 32528295 | Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32528295 | PubMed |
| 10 | 21080186 | Pharmacokinetics of levodopa. | J Neurol | 2010 | https://conductscience.org/library/papers/21080186 | PubMed |
| 11 | 27548849 | Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression. | Mov Disord | 2016 | https://conductscience.org/library/papers/27548849 | PubMed |
| 12 | 32813147 | Genetics of Parkinson's disease. | Acta Neurol Belg | 2020 | https://conductscience.org/library/papers/32813147 | PubMed |
| 13 | 25637461 | Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity. | Acta Neuropathol Commun | 2015 | https://conductscience.org/library/papers/25637461 | PubMed |
| 14 | 37667938 | A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocin. | Eur Rev Med Pharmacol Sci | 2023 | https://conductscience.org/library/papers/37667938 | PubMed |
| 15 | 31620963 | Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis. | Daru | 2019 | https://conductscience.org/library/papers/31620963 | PubMed |
| 16 | 39156113 | The relation between Parkinson's disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39156113 | PubMed |
| 17 | 24269733 | The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. | Neurobiol Dis | 2014 | https://conductscience.org/library/papers/24269733 | PubMed |
| 18 | 33431024 | A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. | J Cheminform | 2020 | https://conductscience.org/library/papers/33431024 | PubMed |
| 19 | 30519161 | Divergent Effects of Metformin on an Inflammatory Model of Parkinson's Disease. | Front Cell Neurosci | 2018 | https://conductscience.org/library/papers/30519161 | PubMed |
| 20 | 24625392 | Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort. | Am J Pathol | 2014 | https://conductscience.org/library/papers/24625392 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42872064 | HMGB1 functional plasticity in neurodegenerative diseases and its translational implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42872064 | PubMed |
| 42515753 | Context-Dependent Modulation of Ferroptosis by Metformin: Mechanisms, Therapeutic Implications and Open Questions. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515753 | PubMed |
| 42039690 | Immunomodulatory and Anti-Inflammatory Effects of Ketotifen Versus Vitamin E in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Pilot Study. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42039690 | PubMed |
| 41898423 | Repurposing Antidiabetic Medications for Parkinson's Disease: Focus on Biomarker Strategies for Disease Modification. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898423 | PubMed |
| 41756254 | LKB1-AMPK Signaling Pathway in Cardiovascular and Other Diseases. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41756254 | PubMed |
| 41601525 | Interplay of oxidative stress and Inflammasome activation and clinical indices in Parkinson's disease: insights from serum SIRT1, Nrf2, and NLRP3 levels and PDQ-39-a cross-sectional study. | Front Neurosci | 2025 | https://conductscience.org/library/papers/41601525 | PubMed |
| 41130438 | Can maternal metformin protect the developing fetal brain? | Am J Obstet Gynecol | 2026 | https://conductscience.org/library/papers/41130438 | PubMed |
| 40649053 | Demographic and Clinical Characteristics of Hospitalized Patients with Type 2 Diabetes Mellitus and Comorbid Parkinson's Disease in Spain: A Nationwide Observational Study (2017-2023). | J Clin Med | 2025 | https://conductscience.org/library/papers/40649053 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BDNF | 627 | PubTator's text mining | https://conductscience.org/library/genes/627 | NCBI Gene |
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| LEVODOPA | CHEMBL1009 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1009 | ChEMBL |
| CARBIDOPA | CHEMBL1200748 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1200748 | ChEMBL |
| METFORMIN | CHEMBL1431 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1431 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40385486
GET https://conductscience.org/api/papers/v1/40385486/references?page=2